COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
The 2019 coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Clinical outcomes, including mortality, are worse in males, older individuals and patients with comorbidities. COPD patients are included in shielding strategies due to their s...
Main Authors: | Andrew Higham, Alexander Mathioudakis, Jørgen Vestbo, Dave Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2020-11-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/29/158/200199.full |
Similar Items
-
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
by: Alexander G. Mathioudakis, et al.
Published: (2019-05-01) -
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
by: Alexander G. Mathioudakis, et al.
Published: (2017-02-01) -
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
by: Alexander G. Mathioudakis, et al.
Published: (2019-11-01) -
Multiple flow rate modelling of nitric oxide in COPD – methodological concerns
by: Kay Roy, et al.
Published: (2006-12-01) -
Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review
by: Alexander G. Mathioudakis, et al.
Published: (2020-12-01)